摘要
支气管哮喘是一种以慢性气道炎症为特征的异质性疾病。近年来哮喘的诊疗趋于精准医学,哮喘的个体化治疗首要是立足于个体化诊断,但哮喘的发病机制复杂及临床表型各异,其高度异质性也带来了实现个体化诊治的巨大挑战,基于多维度、多手段的诊断与评估是重要的实践发展方向。
Bronchial asthma is a heterogeneous disease characterized by chronic airway inflammation.In recent years,the diagnosis and treatment of asthma tend to be precision medicine,and the individualized treatment of asthma is mainly based on individualized diagnosis.However,the pathogenesis of asthma is complex and the clinical phenotype is different,and its high heterogeneity also brings great challenges to realize individualized diagnosis and treatment,Diagnosis and evaluation based on multi-dimensional and multi-means is an important practical development direction.
作者
李宇鹏
张璐璐
霍如婕
田新瑞
Li Yupeng;Zhang Lulu;Huo Rujie;Tian Xinrui(Department of Respiratory and Critical Care Medicine,The Second Hospital of Shanxi Medical University,Taiyuan 030000,China)
出处
《中国综合临床》
2023年第2期126-130,共5页
Clinical Medicine of China
基金
山西省重点研发计划(国际合作)(201903D421066)。
关键词
哮喘
肺功能检查
生物标记物
组学
电子鼻
Asthma
Pulmonary function test
Biomarkers
Omics
Electronic nose
